Icodextrin-associated peritonitis: what conclusions thus far?
Goffin
Eric
E
Division of Nephrology, Université Catholique de Louvain Medical School, 10 Avenue Hippocrate, B-1200 Brussels, Belgium. goffin@nefr.ucl.ac.be
Cosyns
Jean-Pierre
JP
Pirson
Françoise
F
Devuyst
Olivier
O
D015314:Dialysis Solutions / Q000009:adverse effects*; D005936:Glucans / Q000009:adverse effects*; D005947:Glucose / Q000009:adverse effects*; D006801:Humans; D000077607:Icodextrin; D010530:Peritoneal Dialysis / Q000379:methods; D010538:Peritonitis / Q000453:epidemiology / Q000209:etiology* / Q000276:immunology / Q000503:physiopathology*; D015995:Prevalence; D014462:Ultrafiltration / Q000379:methods
D015314:Dialysis Solutions; D005936:Glucans; D000077607:Icodextrin; D005947:Glucose